3,4-dihydroxyphenylacetic acid and valproic acid

3,4-dihydroxyphenylacetic acid has been researched along with valproic acid in 7 studies

Research

Studies (7)

TimeframeStudies, this research(%)All Research%
pre-19901 (14.29)18.7374
1990's0 (0.00)18.2507
2000's3 (42.86)29.6817
2010's3 (42.86)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Asaba, H; Deguchi, T; Hosoya, K; Ohtsuki, S; Otagiri, M; Takanaga, H; Terasaki, T1
Bora-Tatar, G; Dalkara, S; Dayangaç-Erden, D; Demir, AS; Erdem-Yurter, H; Yelekçi, K1
Crespi, F; Keane, PE; Morre, M1
Geisz, A; Klivényi, P; Vámos, E; Vécsei, L; Zádori, D1
Alka, K; Dolly, JO; Henehan, GT; Ryan, BJ1
Baronio, D; Lehtonen, E; Panula, P; Puttonen, HAJ; Semenova, S; Sundvik, M1
Correia, AO; Costa, RO; da Silva Ribeiro, AE; de Barros Viana, GS; de Siqueira, KP; Dos Santos, GCA; Lima, DGS; Lucetti, DL; Lucetti, ECP; Moura, JA; Neves, KRT; Parente, LLT; Silva, MR1

Other Studies

7 other study(ies) available for 3,4-dihydroxyphenylacetic acid and valproic acid

ArticleYear
Role of blood-brain barrier organic anion transporter 3 (OAT3) in the efflux of indoxyl sulfate, a uremic toxin: its involvement in neurotransmitter metabolite clearance from the brain.
    Journal of neurochemistry, 2002, Volume: 83, Issue:1

    Topics: Animals; Antimetabolites; Biological Transport; Blood-Brain Barrier; Brain; Capillaries; Cells, Cultured; Chromatography, High Pressure Liquid; Dose-Response Relationship, Drug; Endothelium, Vascular; GABA Agonists; Homovanillic Acid; Indican; Male; Microinjections; Neurotransmitter Agents; Oocytes; Organic Anion Transporters, Sodium-Independent; p-Aminohippuric Acid; Rats; Rats, Wistar; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Uremia; Xenopus laevis

2002
Molecular modifications on carboxylic acid derivatives as potent histone deacetylase inhibitors: Activity and docking studies.
    Bioorganic & medicinal chemistry, 2009, Jul-15, Volume: 17, Issue:14

    Topics: Caffeic Acids; Carboxylic Acids; Catalytic Domain; Chlorogenic Acid; Curcumin; Enzyme Inhibitors; HeLa Cells; Histone Deacetylase Inhibitors; Histone Deacetylases; Humans; Models, Molecular; Molecular Structure; Protein Binding

2009
Anaesthesia abolishes the effect of valproate on extracellular 5-HIAA, DOPAC and ascorbate as measured in rat striatum by differential pulse voltammetry.
    British journal of pharmacology, 1986, Volume: 87, Issue:1

    Topics: 3,4-Dihydroxyphenylacetic Acid; Anesthesia; Animals; Ascorbic Acid; Corpus Striatum; Dopamine; Hydroxyindoleacetic Acid; Male; Phenylacetates; Rats; Rats, Inbred Strains; Serotonin; Valproic Acid

1986
Valproate ameliorates the survival and the motor performance in a transgenic mouse model of Huntington's disease.
    Pharmacology, biochemistry, and behavior, 2009, Volume: 94, Issue:1

    Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Behavior, Animal; Corpus Striatum; Disease Models, Animal; Disease Progression; Dopamine; Exploratory Behavior; Female; Homovanillic Acid; Huntington Disease; Injections, Intraperitoneal; Kaplan-Meier Estimate; Male; Mice; Mice, Transgenic; Motor Activity; Neuroprotective Agents; Time Factors; Valproic Acid

2009
New inhibitors of the Kvβ2 subunit from mammalian Kv1 potassium channels.
    The international journal of biochemistry & cell biology, 2014, Volume: 55

    Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Binding, Competitive; Brain; Catechols; Cortisone; Kinetics; NADP; Oxidation-Reduction; Potassium Channel Blockers; Potassium Channels, Voltage-Gated; Protein Binding; Rats; Resveratrol; Rutin; Shaker Superfamily of Potassium Channels; Stilbenes; Valproic Acid

2014
Embryonic exposure to valproic acid affects the histaminergic system and the social behaviour of adult zebrafish (Danio rerio).
    British journal of pharmacology, 2018, Volume: 175, Issue:5

    Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Behavior, Animal; Brain; Dopamine beta-Hydroxylase; Histamine; Histidine Decarboxylase; Larva; Locomotion; Male; Neurons; Norepinephrine; Receptors, Histamine; Social Behavior; Tyrosine 3-Monooxygenase; Valproic Acid; Zebrafish

2018
Neuroprotective effects of valproic acid on brain ischemia are related to its HDAC and GSK3 inhibitions.
    Pharmacology, biochemistry, and behavior, 2018, Volume: 167

    Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Brain; Brain Ischemia; Cyclooxygenase 2 Inhibitors; Dopamine; Dose-Response Relationship, Drug; Glycogen Synthase Kinases; Histone Deacetylase Inhibitors; Lipid Peroxidation; Male; Neuroprotective Agents; Nitric Oxide Synthase Type II; Nitrites; Rats; Valproic Acid

2018